The Zhitong Finance App learned that on Monday EST, Beta Bionics, a medical device technology company that produces an algorithm-based automated insulin delivery system for type 1 diabetics, submitted an initial public offering application to the US Securities and Exchange Commission (SEC) and plans to raise 100 million US dollars.

Zhitongcaijing · 01/07 08:01
The Zhitong Finance App learned that on Monday EST, Beta Bionics, a medical device technology company that produces an algorithm-based automated insulin delivery system for type 1 diabetics, submitted an initial public offering application to the US Securities and Exchange Commission (SEC) and plans to raise 100 million US dollars.